To include your compound in the COVID-19 Resource Center, submit it here.

Therapeutics: Thymic stromal lymphopoietin (TSLP); interleukin-33 (IL-33; NF-HEV); IL-25 (IL-17E)

Inflammation

INDICATION: Inflammation; liver fibrosis; pulmonary fibrosis

Mouse studies suggest combined inhibition of IL-33, TSLP and IL-25 could help treat cytokine-driven inflammation

Read the full 215 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE